Literature DB >> 11522471

Serotonin-dopamine interactions in the control of conditioned reinforcement and motor behavior.

D M Sasaki-Adams1, A E Kelley.   

Abstract

These studies addressed the question of serotonin (5-HT)-dopamine (DA) interactions with regard to reward-related behavior and motor activity in rats. The first experiment evaluated the effect of chronic treatment with fluoxetine (7 mg/kg/day), a serotonin-selective reuptake inhibitor, and buproprion (15 mg/kg/day), a dopamine reuptake inhibitor, on responding for conditioned reinforcement (CR). Chronic fluoxetine, but not buproprion, enhanced CR responding, and also potentiated cocaine-induced increases in CR responding. In the second experiment, animals received intra-accumbens infusions of either 5-HT (0, 1, 5, and 10 microg) or DA (10, 20 microg) prior to the conditioned reinforcement test. Dopamine, but not 5-HT, selectively facilitated CR responding, although 5-HT non-specifically increased responding as well. In the third and fourth experiments, it was demonstrated that intra-accumbens 5-HT causes increased motor activity, which was partially blocked by DA antagonists. The results suggest that chronically increased levels of 5-HT may facilitate reward-related behavior, but most likely via indirect modulatory mechanisms affecting general arousal and motor tone.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11522471     DOI: 10.1016/S0893-133X(01)00240-8

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  27 in total

Review 1.  REVIEW: Apathy diagnosis, assessment, and treatment in Alzheimer's disease.

Authors:  Philippe H Robert; Emmanuel Mulin; Patrick Malléa; Renaud David
Journal:  CNS Neurosci Ther       Date:  2010-10       Impact factor: 5.243

Review 2.  Opponency revisited: competition and cooperation between dopamine and serotonin.

Authors:  Y-Lan Boureau; Peter Dayan
Journal:  Neuropsychopharmacology       Date:  2010-09-29       Impact factor: 7.853

3.  Norepinephrine transporter inhibitors and their therapeutic potential.

Authors:  Jia Zhou
Journal:  Drugs Future       Date:  2004-12       Impact factor: 0.148

4.  DARPP-32 mediates serotonergic neurotransmission in the forebrain.

Authors:  Per Svenningsson; Eleni T Tzavara; Feng Liu; Allen A Fienberg; George G Nomikos; Paul Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-05       Impact factor: 11.205

5.  Mood induction effects on motor sequence learning and stop signal reaction time.

Authors:  Brian Greeley; Rachael D Seidler
Journal:  Exp Brain Res       Date:  2016-09-12       Impact factor: 1.972

6.  Two functional serotonin polymorphisms moderate the effect of food reinforcement on BMI.

Authors:  Katelyn A Carr; Henry Lin; Kelly D Fletcher; Lara Sucheston; Prashant K Singh; Robbert J Salis; Richard W Erbe; Myles S Faith; David B Allison; Eric Stice; Leonard H Epstein
Journal:  Behav Neurosci       Date:  2013-04-01       Impact factor: 1.912

7.  Rapid neuroendocrine responses evoked at the onset of social challenge.

Authors:  Michael J Watt; Gina L Forster; Wayne J Korzan; Kenneth J Renner; Cliff H Summers
Journal:  Physiol Behav       Date:  2006-12-20

8.  The Role of Pharmacogenetic Testing in the Amelioration of Antidepressant-Related Motor Disturbances in 2 Young Adult Men With Major Depressive Disorder.

Authors:  Karen H Rhea; William M Petrie; Kathryn R Gardner
Journal:  Prim Care Companion CNS Disord       Date:  2015-01-08

9.  Blockade of serotonin 5-HT1B and 5-HT2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypes.

Authors:  Mark J Millan; Sylvie Veiga; Sylvie Girardon; Mauricette Brocco
Journal:  Psychopharmacology (Berl)       Date:  2003-04-30       Impact factor: 4.530

10.  Influence of fluoxetine on positive and negative affect in a clinic-based smoking cessation trial.

Authors:  Jessica Werth Cook; Bonnie Spring; Dennis E McChargue; Belinda Borrelli; Brian Hitsman; Raymond Niaura; Nancy J Keuthen; Jean Kristeller
Journal:  Psychopharmacology (Berl)       Date:  2004-01-15       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.